申请人:AMP-THERAPEUTICS GMBH
公开号:US20150299256A1
公开(公告)日:2015-10-22
The invention relates to a peptide or peptide derivative having the general formula: Sub
1
-X
1
-D
2
K
3
-P
4
-P
5
-Y
6
-L
7
-P
8
-R
9
-P
10
-X
2
-P
12
- P
13
-R
14
-X
3
-I
16
-P
17
/Y
17
-N
18
-N
19
-X
4
-Sub
2
, wherein X
1
is a non-polar, hydrophobic group pr a positively charged group, D
2
is asparagine or glutamine, K
3
, X
2
, and X
4
are positively charged groups, X
3
is a positively charged group, proline, or a proline derivative; L
7
and I
16
are non-polar, hydrophobic groups, Y
6
and Y
17
are tyrosine, R
9
and R
14
are arginine, N
18
and N
19
are asparagine or glutamine, P
4
, P
5
, P
8
, P
10
, P
12
, P
13
, and P
17
are proline, hydroxyproline, or derivatives thereof, wherein possibly one or two of the groups selected from D
2
, P
4
, P
5
, P
8
, P
10
, P
12
, P
13
, P
17
, and Y
17
are replaced by an arbitrary group and/or P
13
and R
14
are exchanged, Sub
1
is the free or modified N-terminus, and Sub
2
is the free or modified C-terminus. The invention further relates to the use of the peptides and peptide derivatives in medicine, as an antibiotic, in a disinfectant or cleaning agent, as a preservative or in a packaging material, in pharmaceutical research, or in a screening method.